| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 9e-07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |